Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Kerr

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
JAMA Otolaryngology-- Head & Neck Surgery|October 14, 2016
Optimal Perioperative Care in Major Head and Neck Cancer Surgery With Free Flap Reconstruction: A Consensus Review and Recommendations From the Enhanced Recovery After Surgery SocietyJoseph C Dort, D Gregory Farwell, Merran Findlay, et al.
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|May 16, 2013
Treatment of T1b glottic SCC: laser vs. radiation--a Canadian multicenter studyS Mark Taylor, Paul Kerr, Kevin Fung, et al.
British Journal of Haematology|September 27, 2003
The use of stimulated granulocyte transfusions to prevent recurrence of past severe infections after allogeneic stem cell transplantationJ Paul Kerr, Effie Liakopolou, Jessica Brown, et al.
Cancer Immunology, Immunotherapy : CII|June 26, 2012
DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8(+) T-cell responses and increases PSA doubling timeLindsey Chudley, Katy McCann, Ann Mander, et al.
British Journal of Haematology|September 10, 2025
Guidelines from the expert advisory committee on the Safety of Blood, Tissues and Organs (SaBTO) on patient consent and shared decision-making for blood transfusionMichael F Murphy, Damien Carson, Anwen Davies, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2015
Clinical and biological effects of an agonist anti-CD40 antibody: a Cancer Research UK phase I studyPeter Johnson, Ruth Challis, Ferdousi Chowdhury, et al.
The New England Journal of Medicine|May 10, 2013
A no-prophylaxis platelet-transfusion strategy for hematologic cancersSimon J Stanworth, Lise J Estcourt, Gillian Powter, et al.
JAMA Otolaryngology-- Head & Neck Surgery|December 8, 2022
Association of Primary Tumor Volume With Survival in Patients With T3 Glottic Cancer Treated With Radiotherapy: A Study of the Canadian Head & Neck Collaborative Research InitiativeNauman H Malik, Rui Fu, Nicolin Hainc, et al.
Head & Neck|December 20, 2023
Tumor volumes in T3 supraglottic cancers treated with radiotherapy in the modern era: A study of the Canadian Head & Neck Collaborative Research InitiativeNauman H Malik, Rui Fu, Nicolin Hainc, et al.
Vox Sanguinis|March 25, 2025
International Forum on the Use of Irradiated Blood in Patients With Haematological Malignancy: ResponsesXiao-Yin Zhang, Michael Murphy, Graham P Collins, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
JAMA Otolaryngology-- Head & Neck Surgery|October 14, 2016
Optimal Perioperative Care in Major Head and Neck Cancer Surgery With Free Flap Reconstruction: A Consensus Review and Recommendations From the Enhanced Recovery After Surgery SocietyJoseph C Dort, D Gregory Farwell, Merran Findlay, et al.
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|May 16, 2013
Treatment of T1b glottic SCC: laser vs. radiation--a Canadian multicenter studyS Mark Taylor, Paul Kerr, Kevin Fung, et al.
British Journal of Haematology|September 27, 2003
The use of stimulated granulocyte transfusions to prevent recurrence of past severe infections after allogeneic stem cell transplantationJ Paul Kerr, Effie Liakopolou, Jessica Brown, et al.
Cancer Immunology, Immunotherapy : CII|June 26, 2012
DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8(+) T-cell responses and increases PSA doubling timeLindsey Chudley, Katy McCann, Ann Mander, et al.
British Journal of Haematology|September 10, 2025
Guidelines from the expert advisory committee on the Safety of Blood, Tissues and Organs (SaBTO) on patient consent and shared decision-making for blood transfusionMichael F Murphy, Damien Carson, Anwen Davies, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2015
Clinical and biological effects of an agonist anti-CD40 antibody: a Cancer Research UK phase I studyPeter Johnson, Ruth Challis, Ferdousi Chowdhury, et al.
The New England Journal of Medicine|May 10, 2013
A no-prophylaxis platelet-transfusion strategy for hematologic cancersSimon J Stanworth, Lise J Estcourt, Gillian Powter, et al.
JAMA Otolaryngology-- Head & Neck Surgery|December 8, 2022
Association of Primary Tumor Volume With Survival in Patients With T3 Glottic Cancer Treated With Radiotherapy: A Study of the Canadian Head & Neck Collaborative Research InitiativeNauman H Malik, Rui Fu, Nicolin Hainc, et al.
Head & Neck|December 20, 2023
Tumor volumes in T3 supraglottic cancers treated with radiotherapy in the modern era: A study of the Canadian Head & Neck Collaborative Research InitiativeNauman H Malik, Rui Fu, Nicolin Hainc, et al.
Vox Sanguinis|March 25, 2025
International Forum on the Use of Irradiated Blood in Patients With Haematological Malignancy: ResponsesXiao-Yin Zhang, Michael Murphy, Graham P Collins, et al.
Pageof 5